The Future of Drug Development for Neglected Tropical Diseases: How the European Commission Can Continue to Make a Difference

Raymond J. Pierce*, Jane MacDougall, Rob Leurs, Maria Paola Costi

*Corresponding author for this work

Research output: Contribution to JournalShort survey

Abstract

In this article, the four coordinators of neglected tropical disease (NTD) drug development projects funded under the European Commission (EC) Framework Programme 7 argue that the EC should reassess their funding strategy to cover the steps necessary to translate a lead compound into a drug candidate for testing in clinical trials, and suggest ways in which this might be achieved.

Original languageEnglish
Pages (from-to)581-583
Number of pages3
JournalTrends in Parasitology
Volume33
Issue number8
DOIs
Publication statusPublished - 1 Aug 2017

    Fingerprint

Cite this